Retinoic acid receptors — Drug Target

All drugs that target Retinoic acid receptors — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Retinoid · retinoid

Phase 3 pipeline (3)

• Reference: Tazorac Cream, 0.05% · G & W Laboratories Inc. · Retinoid · Dermatology
  Tazorac Cream, 0.05% is a topical retinoid that works by promoting cell turnover and preventing the formation of comedones, thereby reducing acne severity.
• Solaraze 3% Topical Gel · Encube Ethicals Pvt. Ltd. · retinoid · Dermatology
  Solaraze 3% Topical Gel is a topical gel formulation of tazarotene, a retinoid that modulates the expression of genes involved in cell proliferation and differentiation.
• S5G4T-2 · Sol-Gel Technologies, Ltd. · Retinoid · Dermatology
  S5G4T-2 is a topical gel formulation of a retinoid, which works by modulating the activity of retinoic acid receptors in the skin.

Phase 2 pipeline (1)

• CD11301 0.06% · Galderma R&D · retinoid · Dermatology
  CD11301 is a topical retinoid that modulates the retinoic acid pathway to treat acne.